Do We Risk Getting Lost in Such a Wide Range? Thoughts on Interpreting the Continuous Glucose Monitoring-Derived Metrics

Carroll J , Heverly J , Phillip M , et al. International Consensus of continuous glucose monitor use in pharmacological clinical trials in diabetes. Diabetes Technol Ther, 2023; 25(4):217–218.

Battelino T , Danne T , Bergenstal RM et al . Clinical targets for continuous glucose monitoring data interpretation: Recommendations from the International Consensus on Time in Range. Diabetes Care, 2019; 42(8):1593–1603.

Danne T , Nimri R , Battelino T et al. International consensus on use of continuous glucose monitoring. Diabetes Care, 2017; 40(12):1631–1640.

Beck RW , Bergenstal RM , Cheng P , et al. The relationships between time in range, hyperglycemia metrics, and HbA1c. J Diabetes Sci Technol, 2019; 13(4):614–626.

Monnier L , Lapinski H , Colette C . Contributions of fasting and postprandial plasma glucose increments to the overall diurnal hyperglycemia of type 2 diabetic patients: Variations with increasing levels of HbA(1c). Diabetes Care, 2003; 26(3):881–885.

Bianchi C , Aragona M , Rodia C , et al. Freestyle Libre trend arrows for the management of adults with insulin-treated diabetes: A practical approach. J Diabetes Complications, 2019; 33(1):6–12.

Holt RIG , DeVries JH , Hess-Fischl A et al. The management of type 1 diabetes in adults. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetes Care, 2021; 30:dci210043.